Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
Clin Auton Res. 2017 07; 27(Suppl 1):29-31.CA

Links

Publisher Full Text
ncbi.nlm.nih.gov
dx.doi.org
PMC Free PDF

Authors+Show Affiliations

Kremens D
Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
Lew M
Department of Neurology, University of Southern California, Los Angeles, CA, USA. marklew@usc.edu.
Claassen D
Department of Neurology, Vanderbilt University, Nashville, TN, USA.
Goodman BP
Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA.

MeSH

Antiparkinson AgentsDroxidopaDrug Therapy, CombinationFemaleFludrocortisoneHumansHypotension, OrthostaticMiddle AgedMidodrineMineralocorticoidsParkinson DiseaseVasoconstrictor Agents

Pub Type(s)

Case Reports
Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

28674867